But the study also demonstrates that hospitalization rates for COVID, as cited by journalists and policy makers, can be misleading, if not considered carefully. Clearly many patients right now are seriously ill. We also know that overcrowding of hospitals by COVID patients with even mild illness can have negative implications for patients in need of other care. At the same time, this study suggests that COVID hospitalization tallies can’t be taken as a simple measure of the prevalence of severe or even moderate disease, because they might inflate the true numbers by a factor of two.
The first thing to emphasise is that this fall is not the result of some special temporary factor. It isn’t that there was a week of glorious sunshine, the temporary introduction of a new set of restrictions, a sudden change in the testing rules or even the dropping out of the numbers of a previous shock that had temporarily raised numbers. It’s simply that the collective immunity we now have, through a combination of vaccines and people recovered from illness, is sufficient that, given the way we behave (eg more working from home) and given the time of year (August) the virus cannot find enough susceptible people to infect for its rate of spread to accelerate. That means, that, by definition, we have reached what is called the “herd immunity threshold” (HIT) – the collective percentage immunity, across the whole population, at which the virus can no longer sustainably spread.
This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.
Combined with other studies, these data indicate that vaccinated and unvaccinated individuals infected with the Delta variant might transmit infection. Importantly, we show that infectious SARS-CoV-2 is frequently found even in vaccinated persons when specimen Ct values are low.
The arrival of the Delta strain in New Zealand has prompted the country’s Covid-19 response minister to question the efficacy of its ambitious elimination strategy – an approach that has been the backbone of the country’s pandemic response.
…“It does mean that all of our existing protections … start to look less adequate and less robust as a result of that we are looking very closely at what more we can do there. At some point we will have to start to be more open in the future.”
I reiterate our call: “slow down and get the science right—there is no legitimate reason to hurry to grant a license to a coronavirus vaccine.”
FDA should be demanding that the companies complete the two year follow-up, as originally planned (even without a placebo group, much can still be learned about safety). They should demand adequate, controlled studies using patient outcomes in the now substantial population of people who have recovered from covid. And regulators should bolster public trust by helping ensure that everyone can access the underlying data.
Fully vaccinated people carry the same amount of Covid as the unvaccinated, scientists have found in a new study that calls into question the effectiveness of vaccine passports and changes to the NHS app.
…[E]ven the fully jabbed carry high levels of the virus if they become infected and are also more likely to be symptomatic than vaccinated people who pick up an alpha infection.
The results suggest those who are fully jabbed could be as capable of passing on Covid as the unvaccinated, although they are less likely to pick up the virus in the first place.
What [covid jabs] won’t do, according to an increasing body of evidence, is prevent you from being a carrier and thus a danger to others. This somewhat defeats the whole point – and is certainly the only reason international travel has resumed of late.
Last week, in news that hasn’t got nearly enough airtime, Public Health England said in a statement: “Some initial findings […] indicate that levels of virus in those who become infected with Delta having already been vaccinated may be similar to levels found in unvaccinated people. This may have implications for people’s infectiousness, whether they have been vaccinated or not.”
In yet another unexpected and unwelcome twist in the pandemic, the Centers for Disease Control and Prevention released on Friday a report strongly suggesting that fully immunized people with so-called breakthrough infections of the Delta variant can spread the virus to others just as readily as unvaccinated people.
The kids are safe. They always have been.
It may sound strange, given a year of panic over school closures and reopenings, a year of masking toddlers and closing playgrounds and huddling in pandemic pods, that among children the mortality risk from COVID-19 is actually lower than from the flu. The risk of severe disease or hospitalization is about the same.
This is true for the much-worried-over Delta variant. It is also true for all the other variants, and for the original strain. Most remarkably, it has been known to be true since the very earliest days of the pandemic — indeed it was among the very first things we did know about the disease. The preliminary mortality data from China was very clear: To children, COVID-19 represented only a vanishingly tiny threat of death, hospitalization, or severe disease.
Yet for a year and a half we have been largely unwilling to fully believe it. Children now wear masks at little-league games, and at the swimming pool, and when school reopens in the fall they will likely wear masks there, too. But the kids are not at risk themselves, and never were. Now, thanks to vaccines, the vast majority of their parents and grandparents aren’t any longer, either.
Dr. Robert Malone, inventor of the mRNA technology used in the COVID-19 injections, discusses his concerns over their safety and how concerns are censored.
- “I have been written out of history.”
- The chairman of the board of Reuters sits on the board of Pfizer.
- The conflicts of interests are overt…it’s in your face…they have no shame.
- The big thinkers in the government envy the Chinese model of government.
- The political spectrum is irrelevant [on the topic of COVID and vaccines].
- These discussions are forbidden talk so we won’t get to the truth.
- Detailed discussion on the cytotoxic effects of spike proteins and safety of the new mRNA COVID vaccines at around 40mins.
- Dr. Malone agrees with many of Dr. Mike Yeadon‘s comments, except Dr. Yeadon’s conclusion of a conspiracy.
- The figure of 70% uptake of vaccines to reach herd immunity was made up. The data isn’t known. “Somebody is just pulling it out of the air.”
- The vaccines don’t stop you from getting the virus or spreading it.
- The early trials were designed to optimise success.
- You cannot publish stuff outside of the approved memes and that means we can’t do science. People are dying because of this.
- Other treatments have been suppressed to increase uptake of the vaccine.
- The fear is bringing out social pathologies and is diminishing our ability to think.
- We’ve had rampant groupthink in the government, in the WHO and across the world.
- “I’ve never seen this level of co-ordinated crazy.”
- “I’m concerned about what’s at the other side of the tunnel.”
- The new COVID-19 vaccines are still experimental.
- “Most of us who haven’t drunk the Koolaid” say the risk of COVID to children is remarkably low and the risk of vaccines is not nothing.
- There is no logic in vaccinating children, adolescents and young adults. There are some risk and they’re not trivial.
Source links can be found at The Last American Vagabond.
This evidence suggests that serious versions of Covid will continue to be extremely rare in children.
As you can see here, some common activities — and several other diseases — have caused significantly more childhood deaths than Covid has:
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.
The results also show that levels of these antibodies are lower with increasing age and that levels decline over time, providing additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the Autumn.